AI in medicine is both ‘overhyped’ and ‘underhyped,’ says Stanford’s dean

Lloyd Minor, MD, dean of Palo Alto, Calif.-based Stanford University School of Medicine, says artificial intelligence’s long-term effects on medicine are “underhyped,” Politico reported Aug. 23. 

Advertisement

Dr. Minor said when it comes to AI’s long-term impact in medicine, the technology is underhyped, and that when it comes to its immediate impact in medicine, it is overhyped. 

“In the longer term, I think generative AI models are going to become more and more accurate,” he said. “Already today, they are helping physicians to supplement our medical knowledge — knowledge of complex diseases that occur rarely, that even the experts in a narrow field don’t carry around in their head.”

When it comes to being overhyped, Dr. Minor says that there’s a misconception that technology will “eliminate fields of medicine or radically change the way healthcare is practiced over a short period of time.”

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Digital Health

Advertisement

Comments are closed.